Top

Tag: ACELYRIN


Mergers and Acquisitions

ACELYRIN acquires ValenzaBio, strengthens immunology position

January 6, 2023

Via: Pharmaphorum

The acquisition adds multiple clinical and pre-clinical immunology assets to the company’s own immunology pipeline – led by izokibep, a small therapeutic protein inhibitor of interleukin-17A (IL-17A), designed to overcome the limitations of monoclonal antibodies – and includes a potentially […]